NCT00227617 2023-05-22Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsUniversity of California, San FranciscoPhase 2/3 Terminated36 enrolled 14 charts
NCT00804830 2018-08-28Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid CancerRegion SkanePhase 2 Terminated15 enrolled